United States Biotechnology & Medical Research

Clovis Oncology Inc (CLVS)

Track

Ticker: CLVS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Clovis Oncology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 2 Nov 2022
Value US$2,243,951.84 | Price 245.42 | Shares 66,716 (+7.2%)
Sale 2 Nov 2022
Value US$3,496,782.96 | Price 259.39 | Shares 24,512 (+30.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-03 2022-11-02 S Sale
Rolfe Lindsey

See Remarks

Officer
66,716 +7.2%
245.42
US$2,243,952 		66,716 +7.2% 245.42 US$2,243,952
2022-11-03 2022-11-02 S Sale
Rolfe Lindsey

See Remarks

Officer
24,512 +30.6%
259.39
US$3,496,783 		24,512 +30.6% 259.39 US$3,496,783
2022-11-03 2022-11-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
41,114 +23.5%
216.99
US$1,879,895 		41,114 +23.5% 216.99 US$1,879,895
2022-11-03 2022-11-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
915 -4.5%
0.98
US$899 		915 -4.5% 0.98 US$899
2022-11-03 2022-11-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
788 -4.1%
0.98
US$775 		788 -4.1% 0.98 US$775
2022-11-03 2022-11-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,006 -0.7%
0.98
US$1,972 		2,006 -0.7% 0.98 US$1,972
2022-11-03 2022-11-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
1,675 -0.6%
0.98
US$1,646 		1,675 -0.6% 0.98 US$1,646
2022-11-03 2022-11-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,066 -1.9%
0.98
US$2,031 		2,066 -1.9% 0.98 US$2,031
2022-11-03 2022-11-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,513 -2.4%
0.98
US$2,470 		2,513 -2.4% 0.98 US$2,470
2022-11-03 2022-11-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,135 -2.1%
0.98
US$2,098 		2,135 -2.1% 0.98 US$2,098
2022-11-03 2022-11-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,595 -2.6%
0.98
US$2,551 		2,595 -2.6% 0.98 US$2,551
2022-10-04 2022-10-03 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
6 -0.2%
1.29
US$8 		6 -0.2% 1.29 US$8
2022-09-06 2022-09-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,308 -2.4%
1.20
US$2,770 		2,308 -2.4% 1.20 US$2,770
2022-09-06 2022-09-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,234 -2.2%
1.20
US$2,681 		2,234 -2.2% 1.20 US$2,681
2022-09-06 2022-09-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
172 -4.5%
1.20
US$206 		172 -4.5% 1.20 US$206
2022-09-06 2022-09-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
1,444 -7.5%
1.20
US$1,733 		1,444 -7.5% 1.20 US$1,733
2022-09-06 2022-09-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,234 -0.8%
1.20
US$2,681 		2,234 -0.8% 1.20 US$2,681
2022-09-06 2022-09-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,545 -2.3%
1.20
US$3,054 		2,545 -2.3% 1.20 US$3,054
2022-08-03 2022-08-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,169 -2.4%
1.46
US$3,169 		2,169 -2.4% 1.46 US$3,169
2022-08-03 2022-08-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,638 -2.9%
1.46
US$3,854 		2,638 -2.9% 1.46 US$3,854
2022-08-03 2022-08-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,100 -2.1%
1.46
US$3,068 		2,100 -2.1% 1.46 US$3,068
2022-08-03 2022-08-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,554 -2.7%
1.46
US$3,731 		2,554 -2.7% 1.46 US$3,731
2022-08-03 2022-08-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,391 -2.2%
1.46
US$3,493 		2,391 -2.2% 1.46 US$3,493
2022-08-03 2022-08-02 S Sale
Rolfe Lindsey

See Remarks

Officer
1,939 -1.8%
1.46
US$2,833 		1,939 -1.8% 1.46 US$2,833
2022-08-03 2022-08-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
77 -2.3%
1.46
US$112 		77 -2.3% 1.46 US$112
2022-08-03 2022-08-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
930 -5.4%
1.46
US$1,359 		930 -5.4% 1.46 US$1,359
2022-08-03 2022-08-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
802 -4.9%
1.46
US$1,172 		802 -4.9% 1.46 US$1,172
2022-08-03 2022-08-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,100 -0.7%
1.46
US$3,068 		2,100 -0.7% 1.46 US$3,068
2022-08-03 2022-08-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
1,702 -0.6%
1.46
US$2,487 		1,702 -0.6% 1.46 US$2,487
2022-07-06 2022-07-05 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
7 -0.2%
2.71
US$19 		7 -0.2% 2.71 US$19
2022-06-03 2022-06-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
218 -6.3%
0.64
US$140 		218 -6.3% 0.64 US$140
2022-06-03 2022-06-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
1,504 -9.3%
0.64
US$966 		1,504 -9.3% 0.64 US$966
2022-06-03 2022-06-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,403 -2.8%
0.64
US$1,544 		2,403 -2.8% 0.64 US$1,544
2022-06-03 2022-06-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,650 -2.5%
0.64
US$1,703 		2,650 -2.5% 0.64 US$1,703
2022-06-03 2022-06-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,327 -2.5%
0.64
US$1,495 		2,327 -2.5% 0.64 US$1,495
2022-06-03 2022-06-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,327 -0.8%
0.64
US$1,495 		2,327 -0.8% 0.64 US$1,495
2022-05-03 2022-05-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,062 -2.3%
1.97
US$4,062 		2,062 -2.3% 1.97 US$4,062
2022-05-03 2022-05-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,508 -2.9%
1.97
US$4,940 		2,508 -2.9% 1.97 US$4,940
2022-05-03 2022-05-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,062 -0.7%
1.97
US$4,062 		2,062 -0.7% 1.97 US$4,062
2022-05-03 2022-05-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
1,671 -0.6%
1.97
US$3,292 		1,671 -0.6% 1.97 US$3,292
2022-05-03 2022-05-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,062 -2.5%
1.97
US$4,062 		2,062 -2.5% 1.97 US$4,062
2022-05-03 2022-05-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,508 -3.1%
1.97
US$4,940 		2,508 -3.1% 1.97 US$4,940
2022-05-03 2022-05-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,348 -2.3%
1.97
US$4,625 		2,348 -2.3% 1.97 US$4,625
2022-05-03 2022-05-02 S Sale
Rolfe Lindsey

See Remarks

Officer
1,904 -1.9%
1.97
US$3,750 		1,904 -1.9% 1.97 US$3,750
2022-05-03 2022-05-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
76 -2.5%
1.97
US$150 		76 -2.5% 1.97 US$150
2022-05-03 2022-05-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
913 -6.4%
1.97
US$1,798 		913 -6.4% 1.97 US$1,798
2022-05-03 2022-05-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
787 -6.0%
1.97
US$1,550 		787 -6.0% 1.97 US$1,550
2022-04-05 2022-04-04 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
7 -0.2%
2.66
US$19 		7 -0.2% 2.66 US$19
2022-03-03 2022-03-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
871 -23.6%
1.87
US$1,625 		871 -23.6% 1.87 US$1,625
2022-03-03 2022-03-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
9 -0.5%
1.87
US$17 		9 -0.5% 1.87 US$17
2022-03-03 2022-03-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
6,780 -36.8%
1.87
US$12,651 		6,780 -36.8% 1.87 US$12,651
2022-03-03 2022-03-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
166 -2.4%
1.87
US$310 		166 -2.4% 1.87 US$310
2022-03-03 2022-03-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
10,416 -12.0%
1.87
US$19,436 		10,416 -12.0% 1.87 US$19,436
2022-03-03 2022-03-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
290 -0.4%
1.87
US$541 		290 -0.4% 1.87 US$541
2022-03-03 2022-03-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
10,416 -3.7%
1.87
US$19,436 		10,416 -3.7% 1.87 US$19,436
2022-03-03 2022-03-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
354 -0.1%
1.87
US$661 		354 -0.1% 1.87 US$661
2022-03-03 2022-03-02 S Sale
Rolfe Lindsey

See Remarks

Officer
10,585 -9.9%
1.87
US$19,752 		10,585 -9.9% 1.87 US$19,752
2022-03-03 2022-03-02 S Sale
Rolfe Lindsey

See Remarks

Officer
360 -0.4%
1.87
US$672 		360 -0.4% 1.87 US$672
2022-03-03 2022-03-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
10,416 -11.2%
1.87
US$19,436 		10,416 -11.2% 1.87 US$19,436
2022-03-03 2022-03-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
290 -0.4%
1.87
US$541 		290 -0.4% 1.87 US$541
2022-02-03 2022-02-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
81 -4.7%
1.94
US$157 		81 -4.7% 1.94 US$157
2022-02-03 2022-02-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
1,094 -14.0%
1.94
US$2,122 		1,094 -14.0% 1.94 US$2,122
2022-02-03 2022-02-02 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
943 -13.6%
1.94
US$1,829 		943 -13.6% 1.94 US$1,829
2022-02-03 2022-02-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,493 -2.8%
1.94
US$4,836 		2,493 -2.8% 1.94 US$4,836
2022-02-03 2022-02-02 S Sale
Rolfe Lindsey

See Remarks

Officer
2,021 -2.3%
1.94
US$3,920 		2,021 -2.3% 1.94 US$3,920
2022-02-03 2022-02-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,453 -3.6%
1.94
US$4,758 		2,453 -3.6% 1.94 US$4,758
2022-02-03 2022-02-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
2,983 -4.5%
1.94
US$5,786 		2,983 -4.5% 1.94 US$5,786
2022-02-03 2022-02-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
2,453 -0.9%
1.94
US$4,758 		2,453 -0.9% 1.94 US$4,758
2022-02-03 2022-02-02 S Sale
IVERS-READ GILLIAN C

See Remarks

Officer
1,989 -0.8%
1.94
US$3,858 		1,989 -0.8% 1.94 US$3,858
2022-02-03 2022-02-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,453 -3.3%
1.94
US$4,758 		2,453 -3.3% 1.94 US$4,758
2022-02-03 2022-02-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
2,983 -4.1%
1.94
US$5,786 		2,983 -4.1% 1.94 US$5,786
2022-01-04 2022-01-03 S Sale
2.1
Harding Thomas C.

See Remarks

Officer
7 -0.4%
2.75
US$19 		7 -0.4% 2.75 US$19
2021-12-03 2021-12-02 S Sale
MUEHL DANIEL W

See Remarks

Officer
248 -0.4%
3.00
US$744 		248 -0.4% 3.00 US$744
2021-12-03 2021-12-02 S Sale
Rolfe Lindsey

See Remarks

Officer
346 -0.4%
3.00
US$1,038 		346 -0.4% 3.00 US$1,038
2021-12-03 2021-12-02 S Sale
3.4
Gross Paul Edward

See Remarks

Officer
248 -0.4%
3.00
US$744 		248 -0.4% 3.00 US$744
Explore more

More insider trading research around Clovis Oncology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America